NCT02983071 2023-02-15G1T38, a CDK 4/6 Inhibitor, in Combination With Fulvestrant in Hormone Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast CancerG1 Therapeutics, Inc.Phase 1/2 Unknown102 enrolled